By: Sara Radcliffe CLSA President & CEO December 21, 2017 The California Life Sciences Association (CLSA), along with the California Life Sciences Institute (CLSI), would like to thank everyone – members, board members, national organization partners, strategic partners, academic partners and the California life sciences community – for your membership, support and participation throughout the … Continue reading President’s Corner – 2017 Year in Review
On Dec. 20, Congress passed a sweeping overhaul of the tax code in the form of H.R. 1, the Tax Cuts and Jobs Act. While CLSA did not take a position on the overall legislation, we did work in close collaboration and coordination with BIO and our CLSA member companies to ensure that the Orphan Drug Tax Credit – a meaningful incentive for investment in rare disease therapy innovation – was preserved in the final bill passed by Congress.
This month, Reps. Erik Paulsen (R-Minn.) and Jackie Walorski (R-Ind.) and House Ways & Means Committee Chairman Brady (R-Texas) introduced new legislation to provide a 5-year suspension of the medical device excise tax (H.R. 4617). The current suspension of the 2.3% medical device excise tax expires Dec. 31, 2017.
By Erin Righetti Your free copy of the J.P. Morgan Conference 2018 Survival Guide The teeming influx of life science industry folk in San Francisco during the second week of January represents the zenith of the 36th annual J.P. Morgan Healthcare Conference pilgrimage. Concurrent events add to the draw for the who’s who of life science … Continue reading Your Free Guide to Surviving JPM San Francisco 2018
November 07, 2017 By Jen Ralls 10,000 Fitbit devices to be used for research in national program SAN FRANCISCO–(BUSINESS WIRE)– Fitbit (NYSE:FIT), the leading global wearables brand, announced today it has been selected as the first wearable for use in the national All of Us Research Program established by the White House in 2015. This project is funded by a supplement to a funding award … Continue reading Fitbit Selected for National Institutes of Health (NIH) Precision Medicine Research Program with The Scripps Research Institute (TSRI)
December 1, 2017 By Paola Bonilla The option that patients have right now about participating in research or a pilot program sending health Information remotely to HealthCare Institutions, Providers, Payers and Pharma has shown tremendous benefits in improving patient treatments, including medication. But the more remotely devices usability to send health or medical data, the more … Continue reading Security Of Patient Data During Research and Pilots Programs
On Dec. 6, CLSA hosted our annual End of Year Reception on Capitol Hill in Washington, DC. Over 150 guests attended the reception, including California Reps. Tony Cárdenas, Jimmy Panetta), Jackie Speier, and David Valadao, and staff from more than half of our California congressional delegation’s offices.
On Dec. 8, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit in the United States District Court for the Eastern District of California, seeking to have Senate Bill (SB) 17’s manufacturer reporting requirements declared unconstitutional and void.
After a relatively quiet year in the County of Los Angeles regarding proposed take back legislation, activity has begun to percolate this month.
The California Life Sciences Institute (CLSI) is wrapping up another year on a high note, and would like to express our sincere gratitude to the outstanding companies, volunteers, students, educators, partners, sponsors and others who have joined us to further bolster our thriving California life sciences ecosystem. During 2017, CLSI ‘s FAST and CARB-X accelerator … Continue reading 2017 Year in Review: Poised for Growth & Success